UPM Institutional Repository

Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region


Citation

Bimbo Diaz, Alejandro and Chow, Jeremy and Fan, Kee Hoo and Kok, Wei Koh and Chin, Gary Keong Lee and Wee, Siong Teo and Venketasubramanian, Narayanaswamy and Chun, Chieh Wang and Mehta, Radhika (2023) Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region. Drugs in Context, 12 (3). pp. 1-15. ISSN 1745-1981; eISSN: 1740-4398

Abstract

Edoxaban, a once-daily, direct-acting oral anticoagulant, is approved to prevent stroke or systemic embolism in non-valvular atrial fibrillation (NVAF) and treat venous thromboembolism. The clinical benefit of edoxaban for stroke prevention in Asian patients with NVAF has been demonstrated in clinical and real-world studies. We share early clinical experiences with once-daily edoxaban and discuss its evidence-based use in patients with NVAF in Southeast Asia through several cases of patients at high risk, including frail patients, elderly patients with multiple comorbidities and patients with increased bleeding risk. These cases demonstrate the effectiveness and safety of once-daily edoxaban in patients with NVAF in Southeast Asia.


Download File

[img] Text
107426.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (305kB)

Additional Metadata

Item Type: Article
Divisions: Faculty of Medicine and Health Science
DOI Number: https://doi.org/10.7573/dic.2023-3-3
Publisher: Bioexcel Publishing
Keywords: Atrial fibrillation; Edoxaban; Southeast Asia; Stroke; Good health and well-being
Depositing User: Ms. Nur Faseha Mohd Kadim
Date Deposited: 04 Nov 2024 02:35
Last Modified: 04 Nov 2024 02:35
Altmetrics: http://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.7573/dic.2023-3-3
URI: http://psasir.upm.edu.my/id/eprint/107426
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item